デフォルト表紙
市場調査レポート
商品コード
1619021

心臓再同期療法の市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024~2031年

Cardiac Resynchronization Therapy Market Size, Share, Growth Analysis, By Product, By Application (Intraventricular Desynchrony, Interventricular Desynchrony), By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 242 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.96円
心臓再同期療法の市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024~2031年
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓再同期療法の世界市場規模は2022年に41億米ドルと評価され、2023年の42億9,000万米ドルから2031年には61億5,000万米ドルに成長し、予測期間(2024~2031年)のCAGRは4.6%で成長する見通しです。

心臓再同期療法市場は、対象疾患の罹患率の上昇、心臓発作の有病率の急増、治療への投資の増加、ヘルスケア支出の増加などを背景に成長する見込みです。さらに、技術の進歩、医療機器の近代化、新興市場への進出、老年人口の増加が市場成長をさらに促進します。しかし、不利な医療制度改革、手術部位感染リスクの高まり、機器の高感度化といった課題は、この成長を抑制する可能性があり、予測期間中に対処すべきハードルとなります。これらの力学を理解することは、市場情勢の進化をナビゲートしようとする利害関係者にとって極めて重要です。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析

心臓再同期療法の市場規模:製品別 & CAGR(2024~2031年)

  • 市場概要
  • 心臓再同期療法除細動器
  • 心臓再同期療法ペースメーカー

心臓再同期療法の市場規模:用途別 & CAGR(2024~2031年)

  • 市場概要
  • 心室内非同期
  • 心室間(V-V)非同期性
  • 房室(A-V)非同期

心臓再同期療法の市場規模:エンドユーザー別 & CAGR(2024~2031年)

  • 市場概要
  • 病院と心臓センター
  • 外来手術センター
  • その他

心臓再同期療法の市場規模 & CAGR(2024~2031年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021~2023年)

主要企業プロファイル

  • Medtronic plc(Ireland)
  • Boston Scientific Corporation(USA)
  • Abbott Laboratories(USA)
  • BIOTRONIK SE & Co. KG(Germany)
  • Lepu Medical Technology Co., Ltd.(China)
  • MicroPort Scientific Corporation(China)
  • LivaNova PLC(UK)
  • Medico S.p.A.(Italy)
  • Nihon Kohden Corporation(Japan)
  • Koninklijke Philips N.V.(Netherlands)
  • Japan Lifeline Co., Ltd.(Japan)
  • Shree Pacetronix Ltd.(India)
  • Integer Holdings Corporation(OSCOR Inc.)(USA)
  • Osypka Medical GmbH(Germany)
  • St. Jude Medical, Inc.(acquired by Abbott)(USA)
  • Accellent Inc.(USA)
  • Cameron Health(acquired by Emerson Electric Co.)(USA)
  • Sorin Group(acquired by LivaNova)(Italy)
  • Guidant Corporation(acquired by Boston Scientific)(USA)
  • Cyberonics, Inc.(acquired by Abbott)(USA)

結論と推奨事項

目次
Product Code: SQMIG35D2074

Global Cardiac Resynchronization Therapy Market size was valued at USD 4.1 billion in 2022 and is poised to grow from USD 4.29 billion in 2023 to USD 6.15 billion by 2031, growing at a CAGR of 4.6% during the forecast period (2024-2031).

The cardiac resynchronization therapy market is poised for growth, driven by a rising incidence of target diseases, a surge in heart attack prevalence, increased investment in treatment, and growing healthcare expenditures. Additionally, advancements in technology, modernization of medical equipment, expansion into emerging markets, and a growing geriatric population will further propel market growth. However, challenges such as unfavorable healthcare reforms, heightened risks of surgical site infections, and high sensitivity of devices could restrain this growth, presenting hurdles that need to be addressed during the forecast period. Understanding these dynamics will be crucial for stakeholders looking to navigate the evolving landscape of the cardiac resynchronization therapy market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Resynchronization Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Resynchronization Therapy Market Segmental Analysis

Global Cardiac Resynchronization Therapy Market is segmented by product, application, end user and region. Based on product, the market is segmented into cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers. Based on application, the market is segmented into intraventricular desynchrony, interventricular (V-V) desynchrony and atrioventricular (A-V) desynchrony. Based on end user, the market is segmented into hospitals & cardiac centers, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Resynchronization Therapy Market

The Global Cardiac Resynchronization Therapy market is significantly driven by the escalating prevalence of cardiovascular diseases, which continue to pose a serious health challenge worldwide. Sudden cardiac death accounts for nearly half of all fatalities linked to cardiovascular conditions, underscoring the urgent need for effective interventions. Despite advancements in treatment options, the incidence of heart diseases and associated risk factors is on the rise, leading to an increased demand for cardiac resynchronization therapy devices. With heart failure being one of the primary causes of mortality globally, the necessity for innovative therapies is more critical than ever, prompting growth in this market.

Restraints in the Global Cardiac Resynchronization Therapy Market

A significant restraint in the Global Cardiac Resynchronization Therapy market is the issue of product recalls, which can affect consumer confidence and market growth. For example, Boston Scientific Corporation initiated a recall of its INGENIO family of pacemakers and CRT-Ps in June 2022, which included models like the ADVANTIO DR EL, INGENIO DR EL, and VITALIO DR EL. These devices were distributed in the U.S. between November 2016 and August 2022, having been manufactured from September 2016 to December 2018, totaling around 48,000 units. The recall was prompted by concerns that the devices could inadvertently enter safety mode, posing risks to patients' well-being.

Market Trends of the Global Cardiac Resynchronization Therapy Market

The Global Cardiac Resynchronization Therapy (CRT) market is currently experiencing significant growth driven by the rising prevalence of cardiovascular diseases and the need for effective heart failure management. CRT-Defibrillators (CRT-D), which not only promote synchronized heart contractions but also address life-threatening arrhythmias, are becoming increasingly vital in patient treatment strategies. Innovations such as smartphone connectivity and integrated applications are enhancing patient engagement and enabling remote monitoring, further augmenting their appeal. Additionally, advancements in device design, including improved battery life and MRI compatibility, are positioning CRT-D devices as critical tools in modern cardiology, reflecting a robust upward trend in this market.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Cardiac Resynchronization Therapy Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Cardiac Resynchronization Therapy Defibrillators
  • Cardiac Resynchronization Therapy Pacemakers

Global Cardiac Resynchronization Therapy Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Intraventricular Desynchrony
  • Interventricular (V-V) Desynchrony
  • Atrioventricular (A-V) Desynchrony

Global Cardiac Resynchronization Therapy Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Hospitals & Cardiac Centers
  • Ambulatory Surgery Centers
  • Others

Global Cardiac Resynchronization Therapy Market Size & CAGR (2024-2031)

  • North America (Product, Application, End User)
    • US
    • Canada
  • Europe (Product, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medico S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nihon Kohden Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Japan Lifeline Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shree Pacetronix Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integer Holdings Corporation (OSCOR Inc.) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Osypka Medical GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • St. Jude Medical, Inc. (acquired by Abbott) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accellent Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cameron Health (acquired by Emerson Electric Co.) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sorin Group (acquired by LivaNova) (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Guidant Corporation (acquired by Boston Scientific) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cyberonics, Inc. (acquired by Abbott) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations